Home/Filings/4/0000899243-22-031660
4//SEC Filing

Squadron Capital LLC 4

Accession 0000899243-22-031660

CIK 0001425450other

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 7:34 AM ET

Size

9.3 KB

Accession

0000899243-22-031660

Insider Transaction Report

Form 4
Period: 2022-09-20
Transactions
  • Exercise of In-Money

    Common Stock

    2022-09-20$0.00/sh+1,525,000$4576,901,764 total
  • Exercise of In-Money

    Warrants (right to buy)

    2022-09-20+1,525,0000 total
    Exercise: $0.00Common Stock (1,525,000 underlying)
Transactions
  • Exercise of In-Money

    Common Stock

    2022-09-20$0.00/sh+1,525,000$4576,901,764 total
  • Exercise of In-Money

    Warrants (right to buy)

    2022-09-20+1,525,0000 total
    Exercise: $0.00Common Stock (1,525,000 underlying)
Footnotes (2)
  • [F1]Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days.
  • [F2]These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Issuer

ORTHOPEDIATRICS CORP

CIK 0001425450

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001719228

Filing Metadata

Form type
4
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 7:34 AM ET
Size
9.3 KB